“Gut microbiota and drug metabolism”
The projects related to the following areas of research will be considered for funding:
- Gut microbiota metabolism/ chemical transformation of drugs with impact on drug efficacy or their adverse events profile
- Gut microbiota influence of drug pharmacokinetics (independently of direct transformation) with impact on drug efficacy or their adverse event profile
Previous Supported Projects
“Liver diseases and gut microbiota"
For the call for project 2018, the scientific committee has chosen to focus on the liver. The liver is a major organ at the interface between the gut and the whole human body. Beyond the gut itself, the liver is the first gate for the entry of microbiota derived products in the circulation, reaching then all other organs with potential beneficial or detrimental effects.
All types of liver related disease research can be proposed such as cirrhosis, primary sclerosing cholangitis, viral hepatitis, alcoholic liver disease and non-alcoholic fatty liver disease notably.